Kindstar Global (Beijing) Medicine Technology
VC Fund
Beijing, China
Kindstar Global (Beijing) Medicine Technology is a VC fund in Beijing focused on Biotechnology and Medical. Kindstar Global (Beijing) Medicine Technology Co., Ltd. (康圣环球) is a Chinese high-tech enterprise that provides advanced specialized inspection services for hospitals.The company is focused on the development and improvement of specialized clinical and personalized medicine.By giving priority to patients' interests, doctors' needs,and following international norms, standards, and industry guidelines, Kindstar Global introduces, researches, and develops advanced technologies and special inspection methods. It provides comprehensive, advanced, and accurate special inspection services for large tertiary hospitals, specialty hospitals, and general hospitals.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Kindstar Global (Beijing) Medicine Technology invests in
Stages Kindstar Global (Beijing) Medicine Technology invests in
Countries Kindstar Global (Beijing) Medicine Technology invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Shiang Huang
|
|||
Investment Focus
Industry
- Biotechnology 3 (75%)
- Medical 2 (50%)
- Health Care 2 (50%)
- Life Science 1 (25%)
- Medical Device 1 (25%)
Stage
- Seed 2 (50%)
- Corporate Round 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Shiang Huang
Founder, CEO
|
Founder, CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Haixi Biotechnology
|
Haixi Biotechnology is a research and development company of medical testing reagents, aiming to provide accurate testing reagents for medical special inspections, and provide complete scientific research reagents and services for biomedical researchers. Haixi is committed to the R&D, production, sales and service of medical diagnostics andbiomedical research reagent products. | $1.7M / Corporate Round / Dec 02, 2021 | |
NeoImmune
|
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announcedthe completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initiated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products. | $4.7M / Seed / Nov 25, 2021 | |
|
NeoImmune
|
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announcedthe completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initiated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products. | $4.7M / Seed / Nov 25, 2021 | |
TaiLai Biosciences
|
TaiLai Biosciences is a biotechnology company formed by a senior medical industry team and a cutting-edge scientific team to provide a new generation of biopsy products and services based on proprietary biomultiomics technology. TaiLai Biosciences is a provider of bio-based proprietary bio-technology multi-omics a new generation of products andservices biopsy biotechnology companies. Multiomics contains huge amounts of biological information such as DNA, RNA, metabolic small molecules, proteins, and human microbiome. Multiomics technology is a technology to find the correlation between these information through bioinformatics and computational science. | Seed / Jan 10, 2020 |
Co-Investors
Spark Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kindstar Global (Beijing) Medicine Technology invest in?
Kindstar Global (Beijing) Medicine Technology invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Corporate Round stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kindstar Global (Beijing) Medicine Technology?
Public channels for Kindstar Global (Beijing) Medicine Technology include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Kindstar Global (Beijing) Medicine Technology?
The team at Kindstar Global (Beijing) Medicine Technology includes Shiang Huang (Founder, CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
